DOROTHY SAUCEDO: Open Payments
NPI 1881925691 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,074 in 38 payments from 11 companies in 2025. Trend: 2023 $904 · 2024 $1,097 · 2025 $1,074
Food & beverage: $1,075
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $322 |
| Novo Nordisk Inc | 13 | $318 |
| Lilly USA, LLC | 5 | $195 |
| Astellas Pharma US Inc | 4 | $71 |
| Abbott Laboratories | 2 | $44 |
| Currax Pharmaceuticals LLC | 2 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| Organon LLC | 1 | $21 |
| Exact Sciences Corporation | 1 | $17 |
| SI-BONE, INC. | 1 | $15 |
Products named: AIRSUPRA, Ozempic, ZEPBOUND, Wegovy, Rybelsus, MOUNJARO, Veozah, FREESTYLE LIBRE 3.
Industry payments across TX — which companies pay providers there.
